Guiding Stars: I’m Done Losing Weight on a GLP-1—Now What?
Using GLP-1 agonist medications can improve health outcomes for a growing number of conditions including cardiovascular disease, type 2 diabetes, liver disease, and kidney disease. However, it’s no secret that lots of people take them primarily for weight loss.

Energy & Infrastructure

DP World Recognized With 2026 Blue Circle Award for Environmental Leadership in Canada

DP World has been recognized with a 2026 Blue Circle Award by the Vancouver Fraser Port Authority (VFPA), earning distinction in the Energy Action Program category for its ongoing efforts to improve energy efficiency and reduce emissions across its terminal operations.

Idealist to Celebrate 30 Years of Impact in 2026
For thirty years, Idealist has served the social-impact sector in myriad ways. In 2026, the anniversary of idealist.org’s launch, the nonprofit will feature thirty stories of impact and invite community members to share their own stories.
Subscribe to